1. Home
  2. YI vs SRTS Comparison

YI vs SRTS Comparison

Compare YI & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 111 Inc.

YI

111 Inc.

HOLD

Current Price

$3.80

Market Cap

46.4M

ML Signal

HOLD

Logo Sensus Healthcare Inc.

SRTS

Sensus Healthcare Inc.

HOLD

Current Price

$3.03

Market Cap

44.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YI
SRTS
Founded
2010
2010
Country
China
United States
Employees
N/A
N/A
Industry
Retail-Drug Stores and Proprietary Stores
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.4M
44.3M
IPO Year
2018
2016

Fundamental Metrics

Financial Performance
Metric
YI
SRTS
Price
$3.80
$3.03
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.00
AVG Volume (30 Days)
22.2K
24.5K
Earning Date
04-09-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$27,482,000.00
Revenue This Year
N/A
$2.00
Revenue Next Year
N/A
$34.23
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.48
$2.66
52 Week High
$11.17
$5.92

Technical Indicators

Market Signals
Indicator
YI
SRTS
Relative Strength Index (RSI) 40.56 54.06
Support Level $3.41 $2.87
Resistance Level $3.98 $3.17
Average True Range (ATR) 0.33 0.13
MACD 0.02 0.01
Stochastic Oscillator 36.26 55.56

Price Performance

Historical Comparison
YI
SRTS

About YI 111 Inc.

111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.

About SRTS Sensus Healthcare Inc.

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Share on Social Networks: